Surgical treatment of rare endocrine tumors

Diseases of the Pancreas: Current Surgical Therapy

Volumn , Issue , 2008, Pages 735-747

  Egawa, S ^a   Sunamura, M ^a   Matsuno, S ^a   Unno, M ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84872891112     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-28656-1_71     Document Type: Chapter

References (28)

1. Matsuno S, Egawa S, Fukuyama S, Motoi F, Sunamura M, Isaji S, Imaizumi T, Okada S, Kato H, Suda K, Nakao A, Hiraoka T, Hosotani R, Takeda K (2004) Pancreatic Cancer Registry in Japan: 20 years of experience. Pancreas 28:219-230
2. Said SI, Mutt V (1972) Isolation from porcine-intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagons. Eur J Biochem 28:199-204
3. Yamaguchi K, Abe K, Miyakawa S, Ohnami S, Sakagami M, Yanaihara N (1980) The presence of macromolecular vasoactive intestinal polypeptide (VIP) in VIP-producing tumors. Gastroenterology 79:687-694
4. Miller RE, Chernish SM, Greenman GF, Maglinte DD, Rosenak BD, Brunelle RL (1982) Gastrointestinal response to minute doses of glucagon. Radiology 143:317-320
5. Carr-Locke DL, Gregg JA, Aoki TT (1983) Effects of exogenous glucagon on pancreatic and biliary ductal and sphincteric pressures in man demonstrated by endoscopic manometry and correlation with plasma glucagon. Dig Dis Sci 28:312-320
6. Higgins GA, Recant L, Fischman AB (1979) The glucagonoma syndrome: surgically curable diabetes. Am J Surg 137:142-148
7. Marx M, Newman JB, Guice KS, Nealon WH, Townsend CM, Thompson JC (1987) Clinical significance of gastrointestinal hormones. In: Thompson JC, Greeley GH, Rayford PL, Townsend CM Jr (eds) Gastrointestinal Endocrinology. McGraw-Hill, New York, pp 409-428
8. Arnold R, Lankisch PG (1980) Somatostatin and the gastrointestinal tract. Clin Gastroenterol 9:733-753
9. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang ZP, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weisemann, J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong Q, Spiegel AM, Lee Burns A, Marx SJ (1997) Positional cloning of the gene for multiple endocrine neoplasia type 1. Science 276:404-407
10. Zhuang Z, Vortmeyer AO, Pack S, Huang S, Pham TA, Wang C, Park WS, Agarwal SK, Debelenko LV, Kester M, Guru SC, Manickam P, Olufemi SE, Yu F, Heppner C, Crabtree JS, Skarulis MC, Venzon DJ, Emmert-Buck MR, Spiegel AM, Chandrasekharappa SC, Collins FS, Burns AL, Marx SJ, Jensen RT, Liotta LA, Lubensky IA (1997) Somatic mutations in the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res 57:4682-4686
11. Kim WY, Kaelin WG (2005) Role of VHL gene mutation in human cancer. J Clin Oncol 22:4991-5004
12. Chen F, Kishida T, Yao M, Hustad T, Glavac D, Dean M, Gnarra JR, Orcutt ML, Duh FM, Glenn G (1995) Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutat 5:66-75
13. Melmon KL, Rosen SW (1964) Lindau's disease. Am J Med 36:595-617
14. Perren A, Saremaslani P, Schmid S, Bonvin C, Locher T, Roth J, Heitz PU, Komminoth P (2003) DPC4/Smad4: no mutations, rare allelic imbalances, and retained protein expression in pancreatic endocrine tumors. Diagn Mol Pathol 12:181-186
15. Phan GQ, Yeo CJ, Hruban RH, Lillemoe KD, Pitt HA, Cameron JL (1998) Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients. J Gastrointest Surg 2:472-482
16. Imamura M, Takahashi K, Adachi H, Minematsu S, Shimada Y, Naito M, Suzuki T, Tobe T, Azuma T (1987) Usefulness of selective arterial secretin injection test for localization of gastrinoma in the Zollinger-Ellison syndrome. Ann Surg 205:230-239
17. Nauck C, Ivancevic V, Emrich D, Creutzfeldt W (1994) 111 In-pentetreotide (somatostatin analogue) scintigraphy as an imaging procedure for endocrine gastro-entero-pancreatic tumors. Z Gastroenterol 32:323-327
18. Nikou GC, Toubanakis C, Nikolaou P, Giannatou E, Safioleas M, Mallas E, Polyzos A (2005) VIPomas: an update in diagnosis and management in a series of 11 patients. Hepatogastroenterology 52:1259-1265
19. Virgolini I, Traub-Weidinger T, Decristoforo C (2005) Nuclear medicine in the detection and management of pancreatic islet-cell tumours. Best Pract Res Clin Endocrinol Metab 19:213-227
20. Yim JH, Siegel BA, De Benedetti MK, Norton JA, Lairmore TC, Doherty GM (1998) Prospective study of the utility of somatostatin-receptor scintigraphy in the evaluation of patients with multiple endocrine neoplasia type 1. Surgery 124:1037-1042
21. Angeletti S, Corleto VD, Schillaci O, Marignani M, Annibale B, Moretti A, Silecchia G, Scopinaro F, Basso N, Bordi C, Delle Fave G (1998) Use of the somatostatin analogue octreotide to localise and manage somatostatin-producing tumours. Gut 42:792-794
22. Choyke PL, Glenn GM, Walther MM, Patronas NJ, Linehan WM, Zbar B (1995) Von Hippel Lindau disease: genetic, clinical and imaging features. Radiology 146:629-642
23. Peracchi M, Conte D, Gebbia C, Penati C, Pizzinelli S, Arosio M, Corbetta S, Spada A (2003) Plasma chromogranin A in patients with sporadic gastro-entero-pancreatic neuroendocrine tumors or multiple endocrine neoplasia type 1. Eur J Endocrinol 148:39-43
24. Boden G, Ryan IG, Eisenschmid BL, Shelmet JJ, Owen OE (1986) Treatment of inoperable glucagonoma with the longacting somatostatin analogue SMS 201-995. N Engl J Med. 314:1686-1689
25. Altimari AF, Bhoopalam N, O'Dorsio T, Lange CL, Sandberg L, Prinz RA (1986) Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome. Surgery 100:989-996
26. Lips CJ, Hoppener JW, Van Nesselrooij BP, Van der Luijt RB (2005) Counselling in multiple endocrine neoplasia syndromes: from individual experience to general guidelines. J Intern Med 257:69-77
27. Evans DB, Skibber JM, Lee JE, Cleary KR, Ajani JA, Gagel RF, Sellin RV, Fenoglio CJ, Merrell RC, Hickey RC (1993) Nonfunctioning islet cell carcinoma of the pancreas. Surgery 114:1175-1181
28. Chung MH, Pisegna J, Spirt M, Giuliano AE, Ye W, Ramming KP, Bilchik AJ (2001) Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liver. Surgery 130:954-962